PerspectiveAcute Lymphoblastic Leukemia

Of Mice and Men: How an Oncogene Transgresses the Limits and Predisposes to T Cell Acute Lymphoblastic Leukemia

See allHide authors and affiliations

Science Translational Medicine  03 Mar 2010:
Vol. 2, Issue 21, pp. 21ps10
DOI: 10.1126/scitranslmed.3000885

You are currently viewing the abstract.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution


The gene encoding LIM-only 2 (LMO2), an oncogenic transcription factor, is frequently activated in T cell acute lymphoblastic leukemia (T-ALL), but how LMO2 transforms primary hematopoietic cells to induce T-ALL remains an open question. McCormack et al. now show that, in mice, Lmo2 confers self-renewal potential on normally nonrenewing thymocyte progenitor cells, and this property is maintained over four serial transplantations when the cells are transplanted into irradiated mice that lack thymocytes. These leukemia-initiating cells are resistant to irradiation, indicating the need to develop new therapeutic drugs that specifically target the oncogene itself.


  • Citation: T. Hoang, Of mice and men: How an oncogene transgresses the limits and predisposes to T cell acute lymphoblastic leukemia. Sci. Transl. Med. 2, 21ps10 (2010).

View Full Text

Stay Connected to Science Translational Medicine